对《靶向组织蛋白酶的新型 SARS-CoV-2 抑制剂：设计、合成及生物活性》的修正

Correction to "Cathepsin-Targeting SARS-CoV-2 Inhibitors: Design, Synthesis, and Biological Activity".

作者信息

Flury Philipp, Breidenbach Julian, Krüger Nadine, Voget Rabea, Schäkel Laura, Si Yaoyao, Krasniqi Vesa, Calistri Sara, Olfert Matthias, Sylvester Katharina, Rocha Cheila, Ditzinger Raphael, Rasch Alexander, Pöhlmann Stefan, Kronenberger Thales, Poso Antti, Rox Katharina, Laufer Stefan A, Müller Christa E, Gütschow Michael, Pillaiyar Thanigaimalai

机构信息

Institute of Pharmacy, Pharmaceutical/Medicinal Chemistry and Tübingen Center for Academic Drug Discovery, Eberhard Karls University Tübingen, Auf der Morgenstelle 8, Tübingen 72076, Germany.

PharmaCenter Bonn, Pharmaceutical Institute, Pharmaceutical & Medicinal Chemistry, University of Bonn, An der Immenburg 4, Bonn 53121, Germany.

出版信息

ACS Pharmacol Transl Sci. 2024 Mar 6;7(4):1195-1196. doi: 10.1021/acsptsci.4c00095. eCollection 2024 Apr 12.

DOI:10.1021/acsptsci.4c00095

PMID:38633592

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11020060/

Abstract

[This corrects the article DOI: 10.1021/acsptsci.3c00313.].

摘要

[本文更正了文章的数字对象标识符：10.1021/acsptsci.3c00313。]

相似文献

Correction to "Cathepsin-Targeting SARS-CoV-2 Inhibitors: Design, Synthesis, and Biological Activity".对《靶向组织蛋白酶的新型 SARS-CoV-2 抑制剂：设计、合成及生物活性》的修正

ACS Pharmacol Transl Sci. 2024 Mar 6;7(4):1195-1196. doi: 10.1021/acsptsci.4c00095. eCollection 2024 Apr 12.

Correction to "Synergistic Inhibition of SARS-CoV-2 Replication Using Disulfiram/Ebselen and Remdesivir".对“使用双硫仑/依布硒啉和瑞德西韦协同抑制新型冠状病毒复制”的更正。

ACS Pharmacol Transl Sci. 2021 Apr 29;4(3):1246. doi: 10.1021/acsptsci.1c00106. eCollection 2021 Jun 11.

Correction to "Highly Efficient Water-Soluble Photosensitizer Based on Chlorin: Synthesis, Characterization, and Evaluation for Photodynamic Therapy".对“基于二氢卟吩的高效水溶性光敏剂：合成、表征及光动力疗法评估”的修正

ACS Pharmacol Transl Sci. 2022 May 13;5(6):448. doi: 10.1021/acsptsci.2c00084. eCollection 2022 Jun 10.

Peptidomimetics as potent dual SARS-CoV-2 cathepsin-L and main protease inhibitors: In silico design, synthesis and pharmacological characterization.肽拟似物作为强效的 SARS-CoV-2 组织蛋白酶 L 和主蛋白酶双重抑制剂：计算机设计、合成与药理学特性。

Eur J Med Chem. 2024 Feb 15;266:116128. doi: 10.1016/j.ejmech.2024.116128. Epub 2024 Jan 9.

Cathepsin inhibitors nitroxoline and its derivatives inhibit SARS-CoV-2 infection.组织蛋白酶抑制剂硝呋太尔及其衍生物能抑制 SARS-CoV-2 感染。

Antiviral Res. 2023 Aug;216:105655. doi: 10.1016/j.antiviral.2023.105655. Epub 2023 Jun 23.

Modelling how increased Cathepsin B/L and decreased TMPRSS2 usage for cell entry by the SARS-CoV-2 Omicron variant may affect the efficacy and synergy of TMPRSS2 and Cathepsin B/L inhibitors.模拟 SARS-CoV-2 奥密克戎变异株中 Cathepsin B/L 的增加和 TMPRSS2 用于细胞进入的减少如何影响 TMPRSS2 和 Cathepsin B/L 抑制剂的疗效和协同作用。

J Theor Biol. 2023 Sep 7;572:111568. doi: 10.1016/j.jtbi.2023.111568. Epub 2023 Jun 30.

Correction to "Target-Driven Design of a Coumarinyl Chalcone Scaffold Based Novel EF2 Kinase Inhibitor Suppresses Breast Cancer Growth ".对“基于香豆素基查尔酮支架的新型EF2激酶抑制剂的靶向驱动设计抑制乳腺癌生长”的修正

ACS Pharmacol Transl Sci. 2021 May 4;4(3):1247. doi: 10.1021/acsptsci.1c00113. eCollection 2021 Jun 11.

Correction to "On the Relationship between Classic Psychedelics and Suicidality: A Systematic Review".《关于经典致幻剂与自杀倾向之间的关系：一项系统综述》的勘误

ACS Pharmacol Transl Sci. 2022 Feb 22;5(3):176. doi: 10.1021/acsptsci.2c00014. eCollection 2022 Mar 11.

Correction to "Understanding How Phosphorylation and Redox Modifications Regulate Cardiac Ryanodine Receptor Type 2 Activity to Produce an Arrhythmogenic Phenotype in Advanced Heart Failure".对《理解磷酸化和氧化还原修饰如何调节心脏2型兰尼碱受体活性以在晚期心力衰竭中产生致心律失常表型》的勘误

ACS Pharmacol Transl Sci. 2020 Oct 19;3(6):1422. doi: 10.1021/acsptsci.0c00148. eCollection 2020 Dec 11.

Correction to "The Quest for Secondary Pharmaceuticals: Drug Repurposing/Chiral-Switches Combination Strategy".对《寻找二线药物：药物再利用/手性转换组合策略》的勘误

ACS Pharmacol Transl Sci. 2024 Aug 21;7(9):2900. doi: 10.1021/acsptsci.4c00485. eCollection 2024 Sep 13.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验